key: cord-0952850-7y3hv803 authors: Capecchi, Pier Leopoldo; Lazzerini, Pietro Enea; Brillanti, Stefano title: Comment to the letter of Bril F et al. “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?” date: 2021-05-05 journal: J Hepatol DOI: 10.1016/j.jhep.2021.04.039 sha: 1b425b46825886a4a89a9de53c035016ffa399f7 doc_id: 952850 cord_uid: 7y3hv803 nan Conversely, autoimmune diseases are rather commonly observed to present in the postpartum period 4,5 , particularly tyroiditis 6 and rheumatoid arthritis 4 . Nevertheless several cases of autoimmune hepatitis (AIH) have also been reported 7, 8, 9 and the addition of such a disease to the list of autoimmune conditions that may first present after pregnancy has been suggested 9 . Thus, we wonder whether in the case report of Bril et al., the recent pregnancy rather than the administration of the COVID-19 vaccine is the event to possibly associate with the development of AIH. In favour of such a hypothesis also stands the time of J o u r n a l P r e -p r o o f latency before clinical presentation which is more consistent with pregnancy as the causative event. In fact, symptoms of postpartum AIH have been reported to occur from few days to one year after delivery, usually within 4 month9,10, but cases with early appearance are often difficult to differentiate from non-autoimmune pregnancyassociated liver damage10. In this sense, we agree with the authors that in terms of pharmacovigilance the case can be appropriately reported as AIH as a possible expression of a vaccine-related adverse event/reaction. However, the concomitant history of a recent pregnancy represents a tremendous confounding factor, not contributing to solve the dilemma whether vaccine is causality or casualty. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty? Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? Pregnancy and autoimmune diseases Pregnancy and autoimmune connective tissue diseases Postpartum thyroiditis Acute seronegative autoimmune hepatitis in the post-partum period Development of anti-centromere antibody-positive autoimmune hepatitis after childbirth Severe Autoimmune Hepatitis First Presenting in the Early Post Partum Period Development of liver dysfunction after delivery is possibly due to postpartum autoimmune hepatitis. A report of three cases